Our Research

Our extensive research experience began in the 1970s with behavioral and biomedical studies focusing on substance use and other health conditions and expanded in the late 1980s with HIV-related research. More recently, we have developed an expertise in hepatitis C research. For the past 24 years, We have been an active member in the New York Node of the National Drug Abuse Treatment Clinical Trials Network (NIDA CTN). The NIDA CTN is a nationwide collaboration dedicated to conducting effectiveness studies of behavioral and pharmacological interventions across a wide range of community-based treatment settings, playing a substantive role in shaping and advancing the treatment of substance use disorders.

Connect with Our Team

Current Projects

Overdose Prevention

Smartphones for Opiate Addiction Recovery (SOAR) 

Funding Agency: NYU  With NIDA support, the NYU investigative team developed and [...]

Read More

Infectious Disease

Preventing Infectious Disease in People who use Drugs 

Funding Agency: Public Health Solutions, Inc., NYC DOHMH With funding from the [...]

Read More

Mental Health

THRIVE: Treatment for Harnessing Resiliency, Improving Emotional Regulation, and Empowering IndiViduals for a Brighter Future

Nearly all (97%) persons in methadone maintenance therapy (MMT) are estimated to [...]

Read More

Recent Scholarly Contributions

Archive

Community Driven Approach

Advancing health equity is at the core of StartCare℠ mission. As such, we strive to conduct behavioral, biomedical and health services research that generates evidence to sustain and scale effective care and prevention practices that meet the needs of our communities.

 We design and develop research projects that apply social justice and racial equity frameworks to address drivers of health disparities and promote access to care. This includes evaluating StartCare℠ services for equitable access, meaningful outcomes, positive participant experience, and community impact to inform quality improvement and program development. Our research portfolio is focused on contributing to and building on evidence-based practices, including innovative behavioral health interventions, HIV and viral hepatitis prevention and treatment, and technological innovations for overdose prevention.

Innovative Care for Infectious Disease

Our infectious disease work is an example of our approach in action. Funded by grants from the New York City Department of Health and Mental Hygiene (NYC DOHMH) Viral Hepatitis Program, and the New York State Department of Health AIDS Institute and Office of Addiction Services and Supports (OASAS), we have demonstrated capacity to design, develop, and implement programs that make routine screening and treatment services more accessible to underserved communities, particularly to people who may not access healthcare settings at all due to stigma and other access-related barriers.